References
Parkin DM, Bray F, Ferlay J, et al.: Global cancer statistics 2002. CA Cancer J Clin 2005, 55:67–73.
Jemal A, Murray T, Ward E, et al.: Cancer statistics, 2005. CA Cancer J Clin 2005, 55:7–9.
Green JA, Kirwan JM, Tierney JF, et al.: Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systemic review and meta-analysis. Lancet 2001, 358:781–786.
Frazer IH: Prevention of cervical cancer through papil lomavirus vaccination. Nat Rev Immunol 2004, 4:46–54.
Cohen J: High hopes and dilemmas for a cervical cancer vaccine. Science 2005, 308:618–621.
Ault K, Sings H, Bautista O, et al.: Minimum serum antibody levels associated with protection from human papilloma 16 reinfection among placebo subjects. J Clin Oncol 2005, 23(16S):461s.
Washam C: Targeting teens and adolescents for HPV vaccine could draw fire. J Natl Cancer Inst 2005, 97:1030–1031.
Arnst C: O.K., roll up your sleeve: New vaccines are arriving but the economics are still a challenge. Business Week; July 25, 2005.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Markman, M. Turning cervix cancer into a "rare disease": Is society prepared to do what is required to make this a reality?. Curr Oncol Rep 8, 1–2 (2006). https://doi.org/10.1007/s11912-006-0001-0
Issue Date:
DOI: https://doi.org/10.1007/s11912-006-0001-0